Nathan Rich analyst GOLDMAN SACHS

Currently out of the existing stock ratings of Nathan Rich, 26 are a SELL (22.61%), 48 are a BUY (41.74%), 41 are a HOLD (35.65%).

Nathan Rich

Work Performance Price Targets & Ratings Chart

Analyst Nathan Rich works at GOLDMAN SACHS with a stock forecast success ratio of 63.64% fulfilled within 95.91 days on average.

Nathan Rich’s has documented 228 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OSCR, Oscar Health at 09-May-2024.

Wall Street Analyst Nathan Rich

Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $3.53 (9.68%) receiving and performance score of 48.4.

Average potential price target upside

CVET Covetrus HSIC Henry Schein IDXX IDEXX Laboratories OSCR Oscar Health PDCO Patterson Companies SDC SmileDirectClub XRAY Dentsply Sirona ALHC Alignment Healthcare LLC AMRX Amneal Pharmaceuticals, . Common Stock BHG Bright Health Group CVS CVS Health Corp ELAN Elanco Animal Health NVST Envista Holdings Corp ZTS Zoetis UNH UnitedHealth Group orporated CNC Centene Corp HUM Humana MOH Molina Healthcare SONX Sonendo TEVA Teva Pharma Industries Ltd ADR ALGN Align Technology VTRS Viatris

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$1.01 (4.81%)

1 years 11 months 5 days ago

3/4 (75%)

$1.33 (6.43%)




$0.01 (0.05%)


1 years 11 months 22 days ago

0/4 (0%)

$0.3 (1.45%)


1 years 11 months 25 days ago

1/3 (33.33%)

$7.54 (38.75%)




$0.01 (0.05%)

1 years 11 months 25 days ago

1/2 (50%)

$1.3 (6.60%)




1 years 11 months 25 days ago

0/2 (0%)

$6.55 (42.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Nathan Rich is most bullish on?

Potential upside of $106.55 has been obtained for IDXX (IDEXX LABORATORIES)

Which stock is Nathan Rich is most reserved on?

Potential downside of -$5.29 has been obtained for TEVA (TEVA PHARMA INDUSTRIES LTD ADR)

What Year was the first public recommendation made by Nathan Rich?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?